• Available Formats
    • Availability
    • Priced From ( in USD )

Customers Who Bought This Also Bought


About This Item


Full Description

  • Interactive PDF of data, projections, and analysis
  • >100 deals involving follow-on biologics (FOBs) identified
  • 700 biosimilars and 245 companies profiled
  • Updates on approvals and pipeline developments
  • Analysis of competitive landscape, defensive strategies, and market share
  • Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
  • Core drivers and IP issues impacting biosimilar growth
  • and much more

Enterprise version also available.